| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Revenue | $9.8B | $8.6B | $8.9B | $9.6B | $8.3B | $1.9B | $1.9B | $2.1B |
| Cost of Revenue | $3.3B | $2.7B | $3.2B | $4.4B | $3.3B | $2.3B | $2.7B | $2.9B |
| Gross Profit | — | — | — | — | — | — | — | — |
| R&D Expense | — | — | — | — | — | — | — | — |
| SG&A Expense | — | — | — | — | — | — | — | — |
| Operating Income | $2.2B | $2.2B | $1.9B | $1.9B | $1.7B | $0.4B | $0.4B | $0.3B |
| Net Income | $1.6B | $1.5B | $1.3B | $1.4B | $1.3B | $1.2B | $1.1B | — |
| EPS (Basic) | $4.84 | $4.83 | $4.22 | $4.46 | $4.12 | $0.76 | $0.77 | $0.65 |
| EPS (Diluted) | $4.81 | $4.83 | $4.22 | $4.45 | $4.11 | $0.76 | $0.77 | $0.65 |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $51.5B | $47.4B | $43.9B | $41.9B | $39.0B | $37.0B | $35.0B | $33.5B |
| Current Assets | $3.3B | $2.9B | $2.8B | $3.2B | $2.7B | $2.1B | $2.1B | $2.2B |
| Cash & Equivalents | $0.0B | $0.0B | $0.0B | $0.0B | $0.0B | $0.0B | $0.0B | $0.1B |
| Total Liabilities | — | — | — | — | — | — | — | — |
| Current Liabilities | $5.6B | $4.8B | $5.1B | $4.6B | $3.8B | $4.1B | $3.2B | $3.3B |
| Stockholders' Equity | — | — | — | — | — | — | — | — |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $3.4B | $3.2B | $3.0B | $2.1B | $2.0B | $2.2B | $2.3B | $2.1B |
| Investing Cash Flow | $-4.9B | $-3.8B | $-3.6B | $-2.6B | $-2.3B | $-2.8B | $-2.5B | $-2.3B |
| Capital Expenditures | — | — | — | $2.7B | $2.4B | $2.9B | $2.5B | $2.4B |
| Financing Cash Flow | $1.5B | $0.5B | $0.5B | $0.7B | $0.3B | $0.6B | $0.1B | — |